Acyclovir

NDC 31722-778 · Camber Pharmaceuticals, Inc.

Generic nameAcyclovir

Dosage formTABLET

RouteORAL

Active ingredient(s)ACYCLOVIR

Strength800 mg/1

Pharmacologic classDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]

Marketing categoryANDA

Packages

31722-778-01 — 100 TABLET in 1 BOTTLE (31722-778-01)

31722-778-05 — 500 TABLET in 1 BOTTLE (31722-778-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16714-885 — acyclovir, 17856-0083 — Acyclovir, 17856-2170 — Acyclovir, 17856-8083 — Acyclovir, 23155-227 — ACYCLOVIR, 23155-228 — ACYCLOVIR, 23155-229 — acyclovir, 23155-962 — Acyclovir, 31722-681 — Acyclovir, 31722-777 — Acyclovir, 33342-439 — Acyclovir, 43063-589 — Acyclovir, 43063-928 — Acyclovir, 43547-499 — acyclovir, 45802-044 — Acyclovir, 48102-028 — ACYCLOVIR, 50090-3250 — acyclovir, 50090-3254 — acyclovir, 50090-5610 — Acyclovir, 50090-6335 — Acyclovir, +172 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels